HPV-based cervical cancer screening and treatment implementation in resource-limited settings
Official title: Administrative and Engagement Core
Funded at Columbia University Health Sciences · NIH-11644473 · Data updated 2026-11-12
A collaborative project to help doctors in South Africa put HPV-based screening and same-day treatment for cervical cancer into routine care, so more people get fast, effective care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 19, 2023 |
| Project end | August 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $213,912 |
| NIH project number | 3U54CA284030-04S2 |
| Project ID | NIH-11644473 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals in resource-constrained settings where cervical cancer screening and treatment are being scaled up, particularly those eligible for HPV-based screen-and-treat programs.
✕Less likely to help
Individuals outside the target public health settings or those not engaged in cervical cancer screening programs may see limited direct benefit.
What this research studies
This project builds on decades of work between Columbia University and the University of Cape Town to bring HPV-based screen-and-treat for cervical cancer into public health and clinical settings in resource-constrained areas. It focuses on operationalizing and scaling up evidence-based HPV screening and same-day treatment, aligning with national guidelines and WHO goals. The team will foster regional collaboration, strengthen decision-making and resource sharing, and build local capacity among implementers, researchers, and stakeholders to sustain impact. The work emphasizes real-world implementation, policy alignment, and practical strategies to reach more people who need cervical cancer prevention and care.
Why it matters
Potential benefit: If successful, this could accelerate cervical cancer elimination by making HPV-based screening and same-day treatment more accessible and efficiently delivered in underserved communities.
How similar studies have gone: Prior trials and guidelines support the safety and feasibility of HPV-based screen-and-treat, and this work extends implementation in real-world health systems.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Castor, Delivette — Columbia University Health Sciences
- Study coordinator: Castor, Delivette
Related research
Other NIH-funded projects on the same topics.
-
Precision phenotyping of emphysema in the elderly: a study in diverse adults
Researchers will look at CT scans and lung tests in older adults to understand different forms of emphysema and how they relate to health outcomes.
-
Cervical cancer screening and treatment rollout in resource-poor settings
A team from Columbia and the University of Cape Town is testing how to best implement affordable, same-day HPV-based screen-and-treat for cervical cancer in public health settings.
-
Understanding SCN3A-related Developmental Epileptic Encephalopathy and Finding Better Treatments
This NIH grant focuses on how SCN3A gene variants cause developmental epileptic encephalopathy and aims to develop more effective therapies for affected patients.
-
mChoice: Boosting PrEP Use and Adherence for Black and Latino MSM with Tailored Training and Support
A national study to help Black and Latino men who have sex with men start and stick with PrEP through culturally matched provider training and patient support.
-
M-CaRE: Mobile clinics and a smart heart-lung care tool for multimorbidity
A mobile, multilingual tool plus community health workers will help screen and manage high blood pressure and COPD in diverse adult patients, especially in underserved areas.
-
Small molecules to block Slit2/ROBO in glioblastoma
A study to test small molecule drugs that block Slit2/ROBO signals to help treat glioblastoma in patients.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.